About
CGTI SIG
The Cell & Gene Therapy Insights Special Interest Group (SIG) brings together leading experts from across the CAR-T ecosystem to address one of the sector's most urgent and timely questions: what comes next for CAR-T cell therapy? This invitation-only initiative provides a trusted, collaborative forum for open discussion and actionable problem-solving — building consensus, defining priorities, and driving meaningful progress for the field.
The Topic
After a decade as the poster child for cell & gene therapy, CAR-T stands at a crossroads: autologous approaches still struggle with complex supply chains, high costs, uneven access, scalability, and limited solid tumor impact, while allogeneic CAR-T has yet to fulfill its early promise. But at the same time, rapid advances in process/analytical technology and gene delivery and editing are unlocking new paths, including in vivo CAR-T, point-of-care manufacturing, and emerging autoimmune applications. This SIG will examine what's next, define realistic routes to success, and share clear guidance with the wider community.
See Discussion Topics
Confirmed participants
Find out more about our confirmed participants.
From Insight to Action
Following the meeting, the Cell & Gene Therapy Insights editorial team will produce a suite of authoritative outputs — including white papers, reports, position pieces, and infographics — designed to inform, inspire, and guide the wider community.
This SIG is just the beginning. Continued follow-up activities and community gatherings will keep momentum strong, ensuring tangible progress as the CAR-T landscape evolves over time.
Register for the outputs
Sponsorship opportunities
Each working group will be open to exclusive sponsorship, delivering:
● Thought leadership – your SME joins or leads a working group discussion, shaping the debate and enjoying very targeted networking
● Brand exposure – via the White Paper and Meeting Report (widely distributed to our Cell & Gene Therapy Insights readers)
● Lead generation – through discussion outputs, such as webinars, articles, and infographics
Get Involved
We're assembling the Steering Committee, agenda, and attendee list now.
Don't miss your opportunity to help shape this landmark initiative.
Register your interestFAQs
Who can participate in the SIG?
+Participation is by invitation only and aimed at senior experts and thought leaders from across the CAR-T cell therapy community. If you're interested in contributing, you can register your interest to be considered.
When and where will the SIG take place?
+The Cell & Gene Therapy Insights SIG will take place virtually on June 16–17, 2026, bringing together up to 60 selected participants from across the globe.
What happens after the meeting?
+Initially, the discussion outcomes will be transformed into a White Paper, reports, and other open-access resources, ensuring the insights and strategies developed by the group have a lasting impact across the sector. Looking further ahead, additional activities and content may include webinars, articles, and in-person SIG member functions and report-outs at major global conferences for the cell & gene therapy sector.
